Article Text

Download PDFPDF
Clinical features of patients with rheumatic diseases and COVID-19 infection in Sarawak, Malaysia
  1. Sharifah Aishah Wan1,
  2. Cheng Lay Teh1,
  3. Benjamin Sachdev Manjit Singh1,
  4. Yaw Kiet Cheong1,
  5. Seow Lin Chuah1,
  6. Ahmad Tirmizi Jobli2
  1. 1 Rheumatology Unit, Sarawak General Hospital, Kuching, Sarawak, Malaysia
  2. 2 Universiti Malaysia Sarawak Faculty of Medicine and Health Sciences, Kota Samarahan, Sarawak, Malaysia
  1. Correspondence to Dr Sharifah Aishah Wan, Sarawak General Hospital, Kuching, Sarawak 93450, Malaysia; shaishah80{at}yahoo.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We read with great interest the article by Ye et al 1 describing the clinical features and outcomes of patients with rheumatic diseases and COVID-19 in Wuhan, China. It concluded that length of hospital stay and mortality were similar between patients with rheumatic diseases and non-rheumatic groups, while respiratory failure was more common in patients with rheumatic diseases infected with COVID-19. D’Silva et al 2 and Zhao et al 3 subsequently highlighted the differences of clinical severity and outcomes in their respective cohorts of patients with rheumatic diseases and COVID-19. Fredi et al 4 presented data from northern Italy which supported an association of elderly age and the presence of comorbidities with a poor outcome of COVID-19 infection, rather than the type of rheumatic disease or background medications. The Global Rheumatology Alliance5 has recently published data of characteristics associated with hospitalisation for COVID-19 among patients with rheumatic diseases. We would like to share the …

View Full Text

Footnotes

  • Contributors All authors were in involved in conception or design, or analysis and interpretation of data, or both. All authors approved the final version of the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Linked Articles